152 related articles for article (PubMed ID: 37081671)
21. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
Zhang M; Truscott J; Davie J
Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
[TBL] [Abstract][Full Text] [Related]
22. A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.
Comiskey DF; Jacob AG; Sanford BL; Montes M; Goodwin AK; Steiner H; Matsa E; Tapia-Santos AS; Bebee TW; Grieves J; La Perle K; Boyaka P; Chandler DS
Oncogene; 2018 Jan; 37(1):95-106. PubMed ID: 28892044
[TBL] [Abstract][Full Text] [Related]
23. K-rasG12V mediated lung tumor models identified three new quantitative trait loci modifying events post-K-ras mutation.
Saito H; Suzuki N
Biochem Biophys Res Commun; 2014 Oct; 452(4):1067-70. PubMed ID: 25245290
[TBL] [Abstract][Full Text] [Related]
24. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.
Sana J; Zambo I; Skoda J; Neradil J; Chlapek P; Hermanova M; Mudry P; Vasikova A; Zitterbart K; Hampl A; Sterba J; Veselska R
Anal Cell Pathol (Amst); 2011; 34(6):303-18. PubMed ID: 22156015
[TBL] [Abstract][Full Text] [Related]
25. Genetic modeling of human rhabdomyosarcoma.
Linardic CM; Downie DL; Qualman S; Bentley RC; Counter CM
Cancer Res; 2005 Jun; 65(11):4490-5. PubMed ID: 15930263
[TBL] [Abstract][Full Text] [Related]
26. You can win by losing: p53 mutations in rhabdomyosarcomas.
Post SM; Lozano G
J Pathol; 2010 Oct; 222(2):124-8. PubMed ID: 20821751
[TBL] [Abstract][Full Text] [Related]
27. Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma.
Takahashi Y; Oda Y; Kawaguchi K; Tamiya S; Yamamoto H; Suita S; Tsuneyoshi M
Mod Pathol; 2004 Jun; 17(6):660-9. PubMed ID: 15098008
[TBL] [Abstract][Full Text] [Related]
28. Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
Tsintari V; Walter B; Fend F; Overkamp M; Rothermundt C; Lopez CD; Schittenhelm MM; Kampa-Schittenhelm KM
BMC Cancer; 2022 Jul; 22(1):725. PubMed ID: 35780096
[TBL] [Abstract][Full Text] [Related]
29. Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins.
Gerhart J; Behling K; Paessler M; Milton L; Bramblett G; Garcia D; Pitts M; Hurtt R; Crawford M; Lackman R; Nguyen D; Infanti J; FitzGerald P; George-Weinstein M
PLoS One; 2019; 14(4):e0214758. PubMed ID: 30973903
[TBL] [Abstract][Full Text] [Related]
30. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
31. Delta-like 1 homolog (dlk1): a marker for rhabdomyosarcomas implicated in skeletal muscle regeneration.
Jørgensen LH; Sellathurai J; Davis EE; Thedchanamoorthy T; Al-Bader RW; Jensen CH; Schrøder HD
PLoS One; 2013; 8(4):e60692. PubMed ID: 23577150
[TBL] [Abstract][Full Text] [Related]
32. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle.
Saab R; Spunt SL; Skapek SX
Curr Top Dev Biol; 2011; 94():197-234. PubMed ID: 21295688
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic Amplification of Zygotic Dux Factors in Regenerating p53-Deficient Muscle Stem Cells Defines a Molecular Cancer Subtype.
Preussner J; Zhong J; Sreenivasan K; Günther S; Engleitner T; Künne C; Glatzel M; Rad R; Looso M; Braun T; Kim J
Cell Stem Cell; 2018 Dec; 23(6):794-805.e4. PubMed ID: 30449715
[TBL] [Abstract][Full Text] [Related]
34. Case Report: A PD-L1-Positive Patient With Pleomorphic Rhabdomyosarcoma Achieving an Impressive Response to Immunotherapy.
Liu J; Liu P; Gong F; Tian Y; Zhao X
Front Immunol; 2022; 13():815598. PubMed ID: 35371041
[TBL] [Abstract][Full Text] [Related]
35. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ
Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482
[TBL] [Abstract][Full Text] [Related]
36. High Frequency of Tumor Propagating Cells in Fusion-Positive Rhabdomyosarcoma.
Generali M; Satheesha S; Bode PK; Wanner D; Schäfer BW; Casanova EA
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573355
[TBL] [Abstract][Full Text] [Related]
37. Pleomorphic rhabdomyosarcoma in children: four cases in the pediatric age group.
Furlong MA; Fanburg-Smith JC
Ann Diagn Pathol; 2001 Aug; 5(4):199-206. PubMed ID: 11510002
[TBL] [Abstract][Full Text] [Related]
38. Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
Schmid E; Stagno MJ; Yan J; Schleicher S; Yu W; Honisch S; Lang F; Fuchs J; Seitz G
Cell Physiol Biochem; 2017; 43(3):1301-1308. PubMed ID: 28992614
[TBL] [Abstract][Full Text] [Related]
39. Case of pleomorphic rhabdomyosarcoma arising on subcutaneous tissue in an adult patient: Review of the published works of 13 cases arising on cutaneous or subcutaneous tissue.
Watanabe M; Ansai SI; Iwakiri I; Fukumoto T; Murakami M
J Dermatol; 2017 Jan; 44(1):59-63. PubMed ID: 27569112
[TBL] [Abstract][Full Text] [Related]
40. A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells.
Koifman G; Shetzer Y; Eizenberger S; Solomon H; Rotkopf R; Molchadsky A; Lonetto G; Goldfinger N; Rotter V
Cancer Res; 2018 Oct; 78(20):5833-5847. PubMed ID: 30154152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
